Immunological and Genomic Analysis Reveals Clinically Relevant Distinctions between Angiosarcoma SubgroupsStefan G. van Ravensteijn, Ingrid M.E. Desar, Leonie I. Kroeze et al.|Cancers|2022Cited by 19
Establishment and characterization of the first patient-derived radiation-induced angiosarcoma xenograft model (RT-AS5)Yvonne M.H. Versleijen‐Jonkers, Uta Flucke, Melissa H.S. Hillebrandt-Roeffen et al.|Scientific Reports|2023Cited by 3
Which angiosarcoma subtypes may benefit from immunotherapy?Stefan G. van Ravensteijn, Ingrid M.E. Desar, Yvonne M.H. Versleijen‐Jonkers et al.|Journal of Clinical Oncology|2022Cited by 2
Author Correction: Establishment and characterization of the first patient-derived radiation-induced angiosarcoma xenograft model (RT-AS5)Yvonne M.H. Versleijen‐Jonkers, Uta Flucke, Melissa H.S. Hillebrandt-Roeffen et al.|Scientific Reports|2025Cited by 0